What is Allay Therapeutics worth?
$126.0Mlast known valuation
Allay Therapeutics last raised $45.0M in its Early Stage VC (Jan 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Allay Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2025 | Early Stage VC | $45.0M | ▮ | ▮ |
| Sep 2021 | Later Stage VC | $86.9M | ▮ | ▮ |
| Apr 2020 | Early Stage VC | $15.0M | ▮ | ▮ |
How Allay Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Allay Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Allay Therapeutics worth?
- Allay Therapeutics's last known valuation is $126.0M.
- How much has Allay Therapeutics raised?
- Allay Therapeutics has raised $174.8M in total funding across 3 recorded rounds.
- When did Allay Therapeutics last raise?
- Allay Therapeutics last raised in Jan 2025 (Early Stage VC), raising $45.0M.